Balmiki Ray

3.5k total citations
51 papers, 2.8k citations indexed

About

Balmiki Ray is a scholar working on Physiology, Genetics and Molecular Biology. According to data from OpenAlex, Balmiki Ray has authored 51 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 12 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Balmiki Ray's work include Alzheimer's disease research and treatments (21 papers), Genetics and Neurodevelopmental Disorders (11 papers) and Cholinesterase and Neurodegenerative Diseases (9 papers). Balmiki Ray is often cited by papers focused on Alzheimer's disease research and treatments (21 papers), Genetics and Neurodevelopmental Disorders (11 papers) and Cholinesterase and Neurodegenerative Diseases (9 papers). Balmiki Ray collaborates with scholars based in United States, Finland and India. Balmiki Ray's co-authors include Debomoy K. Lahiri, Justin M. Long, Nigel H. Greig, Deborah K. Sokol, Duan Liu, Richard M. Weinshilboum, Drew Neavin, Jason A. Bailey, Bryan Maloney and Neelima B. Chauhan and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Balmiki Ray

50 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Balmiki Ray United States	28	1.0k	1.0k	531	399	361	51	2.8k
Changiz Taghibiglou Canada	27	1.8k 1.7×	906 0.9×	1.2k 2.3×	257 0.6×	381 1.1×	56	3.8k
Elizabeth Fernández United States	19	2.3k 2.2×	1.9k 1.9×	425 0.8×	244 0.6×	254 0.7×	33	5.2k
Ian Appleton New Zealand	31	915 0.9×	724 0.7×	424 0.8×	244 0.6×	353 1.0×	51	3.6k
Elisa Mitiko Kawamoto Brazil	29	922 0.9×	661 0.6×	418 0.8×	197 0.5×	465 1.3×	67	2.6k
Shui‐bing Liu China	27	714 0.7×	424 0.4×	473 0.9×	317 0.8×	335 0.9×	72	2.0k
Gloria Patricia Cardona‐Gómez Colombia	31	1.1k 1.0×	870 0.9×	764 1.4×	698 1.7×	792 2.2×	87	3.6k
Qi Yang China	29	831 0.8×	413 0.4×	533 1.0×	167 0.4×	247 0.7×	122	2.4k
Bing Gong China	28	1.4k 1.4×	1.1k 1.1×	472 0.9×	160 0.4×	264 0.7×	52	3.0k
Subbiah Pugazhenthi United States	32	1.8k 1.7×	902 0.9×	422 0.8×	450 1.1×	378 1.0×	82	4.0k

Countries citing papers authored by Balmiki Ray

Since Specialization

Citations

This map shows the geographic impact of Balmiki Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Balmiki Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Balmiki Ray more than expected).

Fields of papers citing papers by Balmiki Ray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Balmiki Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Balmiki Ray. The network helps show where Balmiki Ray may publish in the future.

Co-authorship network of co-authors of Balmiki Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Balmiki Ray. A scholar is included among the top collaborators of Balmiki Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Balmiki Ray. Balmiki Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Branstrom, Arthur, Liangxian Cao, Bansri Furia, et al.. (2022). Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia. Frontiers in Oncology. 12. 832816–832816. 10 indexed citations

Piya, Sujan, Marla Weetall, Josephine Sheedy, et al.. (2020). The Novel Dihydroorotate Dehydrogenase (DHODH) Inhibitor PTC299 Inhibit De Novo Pyrimidine Synthesis with Broad Anti-Leukemic Activity Against Acute Myeloid Leukemia. Blood. 136(Supplement 1). 8–9.

Ray, Balmiki, Bryan Maloney, Kumar Sambamurti, et al.. (2020). Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease. Translational Psychiatry. 10(1). 47–47. 64 indexed citations

Neavin, Drew, Duan Liu, Balmiki Ray, & Richard M. Weinshilboum. (2018). The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases. International Journal of Molecular Sciences. 19(12). 3851–3851. 230 indexed citations

Liu, Duan, Sisi Qin, Balmiki Ray, et al.. (2018). Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction. Drug Metabolism and Disposition. 46(9). 1372–1381. 13 indexed citations

Erickson, Craig A., Balmiki Ray, Logan Wink, et al.. (2016). Initial analysis of peripheral lymphocytic extracellular signal related kinase activation in autism. Journal of Psychiatric Research. 84. 153–160. 5 indexed citations

Lahiri, Debomoy K. & Balmiki Ray. (2014). Intravenous Immunoglobulin Treatment Preserves and Protects Primary Rat Hippocampal Neurons and Primary Human Brain Cultures Against Oxidative Insults. Current Alzheimer Research. 11(7). 645–654. 10 indexed citations

Erickson, Craig A., Balmiki Ray, Bryan Maloney, et al.. (2014). Impact of acamprosate on plasma amyloid-β precursor protein in youth: A pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker. Journal of Psychiatric Research. 59. 220–228. 43 indexed citations

Zhang, Yihong, James Raymick, Sumit Sarkar, et al.. (2013). Efficacy and Toxicity of Clioquinol Treatment and A-beta42 Inoculation in the APP/PSI Mouse Model of Alzheimer’s Disease. Current Alzheimer Research. 10(5). 494–506. 30 indexed citations

10.

Long, Justin M., Balmiki Ray, & Debomoy K. Lahiri. (2013). MicroRNA-339-5p Down-regulates Protein Expression of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) in Human Primary Brain Cultures and Is Reduced in Brain Tissue Specimens of Alzheimer Disease Subjects. Journal of Biological Chemistry. 289(8). 5184–5198. 154 indexed citations

11.

Erickson, Craig A., Logan Wink, Balmiki Ray, et al.. (2013). Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome. Psychopharmacology. 228(1). 75–84. 82 indexed citations

12.

Long, Justin M., Balmiki Ray, & Debomoy K. Lahiri. (2012). MicroRNA-153 Physiologically Inhibits Expression of Amyloid-β Precursor Protein in Cultured Human Fetal Brain Cells and Is Dysregulated in a Subset of Alzheimer Disease Patients. Journal of Biological Chemistry. 287(37). 31298–31310. 163 indexed citations

13.

Tweedie, David, Kelly Fishman, Henriette van Praag, et al.. (2012). Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease. Journal of Neuroinflammation. 9(1). 106–106. 164 indexed citations

14.

Ray, Balmiki, Justin M. Long, Deborah K. Sokol, & Debomoy K. Lahiri. (2011). Increased Secreted Amyloid Precursor Protein-α (sAPPα) in Severe Autism: Proposal of a Specific, Anabolic Pathway and Putative Biomarker. PLoS ONE. 6(6). e20405–e20405. 97 indexed citations

15.

Bailey, Jason A., Balmiki Ray, Nigel H. Greig, & Debomoy K. Lahiri. (2011). Rivastigmine Lowers Aβ and Increases sAPPα Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons. PLoS ONE. 6(7). e21954–e21954. 59 indexed citations

16.

Ray, Balmiki, Savita Bisht, Amarnath Maitra, Anirban Maitra, & Debomoy K. Lahiri. (2011). Neuroprotective and Neurorescue Effects of a Novel Polymeric Nanoparticle Formulation of Curcumin (NanoCurc™) in the Neuronal Cell Culture and Animal Model: Implications for Alzheimer's disease. Journal of Alzheimer s Disease. 23(1). 61–77. 142 indexed citations

17.

Ray, Balmiki, Neelima B. Chauhan, & Debomoy K. Lahiri. (2011). The “Aged Garlic Extract” (AGE) and One of its Active Ingredients S-Allyl-LCysteine (SAC) as Potential Preventive and Therapeutic Agents for Alzheimer's Disease (AD). Current Medicinal Chemistry. 18(22). 3306–3313. 68 indexed citations

18.

Ray, Balmiki, Pradeep Banerjee, Nigel H. Greig, & Debomoy K. Lahiri. (2009). Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (Aβ) peptide in the human neuroblastoma cells. Neuroscience Letters. 470(1). 1–5. 41 indexed citations

19.

Bailey, Jason A., Balmiki Ray, Lakshman Puli, et al.. (2009). Memantine lowers amyloid‐β peptide levels in neuronal cultures and in APP/PS1 transgenic mice. Journal of Neuroscience Research. 88(1). 143–154. 110 indexed citations

20.

Ray, Balmiki, Jay Simon, & Debomoy K. Lahiri. (2009). Determination of high-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in the same population of cultured cells. Brain Research. 1297. 160–168. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact